Easton Pharmaceuticals (Easton Pharmaceuticals) Scaled Net Operating Assets : 0.96 (As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Easton Pharmaceuticals's operating assets for the quarter that ended in Sep. 2021 was $9.97 Mil. Easton Pharmaceuticals's operating liabilities for the quarter that ended in Sep. 2021 was $0.48 Mil. Easton Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2021 was $9.90 Mil. Therefore, Easton Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2021 was 0.96.

Easton Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Easton Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Scaled Net Operating Assets Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

Scaled Net Operating Assets

Get a 7-Day Free Trial

-0.09

0.05

7.13

1.51

0.55

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
Scaled Net Operating Assets	Get a 7-Day Free Trial															1.51	0.55	0.94	0.97	0.96

Competitive Comparison of Easton Pharmaceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Easton Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Easton Pharmaceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Easton Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Easton Pharmaceuticals's Scaled Net Operating Assets falls into.

Easton Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Easton Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2020 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2020 )
=	(Operating Assets (A: Dec. 2020 )	-	Operating Liabilities (A: Dec. 2020 ))	/	Total Assets (A: Dec. 2019 )
=	(10.192	-	0.801)	/	17.172
=	0.55

where

	Operating Assets		(A: Dec. 2020 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	10.192	-	0
=	10.192

	Operating Liabilities		(A: Dec. 2020 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.283	-	2.482	-	0
=	0.801

Easton Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2021 )
=	(Operating Assets (Q: Sep. 2021 )	-	Operating Liabilities (Q: Sep. 2021 ))	/	Total Assets (Q: Jun. 2021 )
=	(9.968	-	0.483)	/	9.898
=	0.96

where

	Operating Assets		(Q: Sep. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	9.968	-	0
=	9.968

	Operating Liabilities		(Q: Sep. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3.32	-	2.837	-	0
=	0.483

Easton Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.